Aligned Genetics, Inc.

Informe acción KOSDAQ:A238120

Capitalización de mercado: ₩64.1b

Aligned Genetics Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Yeon-Cheol Jung

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO20.5%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Apr 06
If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Feb 11
Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

CEO

Yeon-Cheol Jung (53 yo)

no data

Permanencia

Mr. Yeon-Cheol Jung serves as the Chief Executive Officer at Aligned Genetics, Inc. (formerly known as Logos Biosystems, Inc.). Mr. Jung is an Insider at Aligned Genetics, Inc. (formerly known as Logos Bio...